Global BIM Market (Software) Share & Size to Grow US $10.36 Billion by 2022
/
Date10 Apr 2018
New York, NY, April 10, 2018 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Building Information Modeling (BIM) Market by Solution... Read More →
Identiv to Showcase Hirsch and 3vr Product Lineup at ISC West 2018
/
Date10 Apr 2018
FREMONT, Calif., April 10, 2018 (GLOBE NEWSWIRE) — Identiv, Inc. (NASDAQ:INVE) today announced that it will present its wide range of access control, video security... Read More →
Center Coast Brookfield MLP & Energy Infrastructure Fund Monthly Distribution Declaration
/
Date10 Apr 2018
NEW YORK, April 06, 2018 (GLOBE NEWSWIRE) — Center Coast Brookfield MLP & Energy Infrastructure Fund (NYSE:CEN) (the “Fund”) today announced that its Board of... Read More →
International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results
/
Date10 Apr 2018
CARLSBAD, Calif., April 10, 2018 (GLOBE NEWSWIRE) — via NetworkWire — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage... Read More →
Exela Technologies Acquires Asterion International to Expand in Europe
/
Date10 Apr 2018
IRVING, Texas, April 10, 2018 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela”) (NASDAQ:XELA), one of the largest global providers of platforms for business process automation... Read More →
ButcherJoseph & Co. Advised ESOP-owned HB McClure on Acquisition
/
Date10 Apr 2018
ST. LOUIS, April 10, 2018 (GLOBE NEWSWIRE) — ButcherJoseph & Co. (“ButcherJoseph”) served as the exclusive financial advisor to HB McClure Company (“HB McClure” or... Read More →
Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All Multiply
/
Date10 Apr 2018
Raymond C Dabney Cannabis Science Inc., President & CEO Cannabis Science, Inc. IRVINE, CA, April 10, 2018 (GLOBE NEWSWIRE) — Cannabis Science, Inc. (OTC: CBIS),... Read More →
Selecta Biosciences Presents Positive New Data from Ongoing Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at PANLAR 2018 Congress
/
Date10 Apr 2018
3-month Phase 2 data indicate SEL-212 (SVP-Rapamycin + pegsiticase) product profile may provide better and more sustained serum uric acid control, fewer flares, and less... Read More →